Ep193: Ron Renaud on Helping People Lose Weight With GLP-1 Medicines
The Long Run with Luke Timmerman
00:00
What impressed in Hungry's data
Ron describes rebupatide's phase 2 results showing high‑teens weight loss at lower doses with class‑typical tolerability.
Play episode from 12:43
Transcript
